Cancer burden in the year 2000. The global picture

European Journal of Cancer

Volumn 37, Issue SUPPL. 8, 2001, Pages

  Parkin, D M ^a   Bray, F I ^a   Devesa, S S ^b  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; AMOXICILLIN; BETA CAROTENE; CANCER VACCINE; ESTROGEN; HEPATITIS VACCINE; MINERAL; MULTIVITAMIN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PRAZIQUANTEL; RETINOL; RIBOFLAVIN; SELENIUM; STEROID 5ALPHA REDUCTASE INHIBITOR; VITAMIN; ZINC;

BREAST CANCER; CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL TRIAL; COLORECTAL CANCER; DEVELOPED COUNTRY; DEVELOPING COUNTRY; ESOPHAGUS CANCER; GARLIC; HUMAN; LIVER CANCER; LUNG CANCER; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; STOMACH CANCER; UTERINE CERVIX CANCER;

EID: 0034767957     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0959-8049(01)00267-2     Document Type: Review

References (317)

1. Accuracy of cancer death certificates and its effect on cancer mortality statistics
2. Purposes and uses of cancer registration
3. Estimates of the worldwide incidence of 25 cancers in 1990
4. Estimates of the worldwide mortality from 25 cancers in 1990
5. Estimates of the worldwide prevalence for twenty five sites in the adult population
6. Systems and alternative sources of information: China
7. Global and regional mortality patterns by cause of death in 1980
8. Do the predictions for cancer incidence come true? Experience from Finland
9. At least one in seven cases of cancer is caused by smoking. Global estimates for 1985
10. Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type
11. Race and sex differences in lung cancer risk associated with cigarette smoking
12. Gender and smoking-related risk of lung cancer
13. Gender differences in lung cancer risk by smoking: A multicentre case-control study in Germany and Italy
14. Molecular epidemiology of the human glutathione S-Transferase genotypes GSTM1 and GSTT1 in cancer susceptibility
15. Review of studies of selected metabolic polymorphisms and cancer
16. Ethnic differences in the lung cancer risk associated with smoking
17. Lung carcinoma in African Americans and whites. A population-based study in metropolitan Detroit, Michigan
18. A case-control study of lung cancer and environmental tobacco smoke among nonsmoking women living in Shanghai, China
19. Chinese food cooking and lung cancer in women nonsmokers
20. Smoking, air pollution, and the high rates of lung cancer in Shenyang, China
21. Lung cancer
22. Characterization of the lung cancer epidemic in the European Union (1970-1990)
23. Projections of lung cancer mortality in the United States: 1985-2025
24. Trends in lung cancer, chronic obstructive lung disease, and emphysema death rates for England and Wales 1941-85 and their relation to trends in cigarette smoking
25. Changing patterns of lung cancer incidence by histological type
26. United States lung carcinoma incidence trends: Declining for most histologic types among males, increasing among females
27. Tobacco smoking as a possible etiologic factor in brochiogenus carcinoma. A study of six hundred and eighty four proved cases
28. Time trend and the age-period-cohort effect on the incidence of histologic types of lung cancer in Connecticut, 1960-1989
29. Striking changes in smoking behaviour and lung cancer incidence by histological type in south-east Netherlands, 1960-1991
30. Trends of lung cancer incidence by histologic type: A population-based study in Osaka, Japan
31. Assessment of lung cancer risk factors by histologic category
32. Effect of tobacco smoking on various histological types of lung cancer
33. The changing epidemiology of smoking and lung cancer histology
34. The increasing incidence of lung adenocarcinoma: Reality or artefact? A review of the epidemiology of lung adenocarcinoma
35. Mortality in relation to smoking: 20 years' observations on male British doctors
36. Mortality in relation to smoking: 40 years' observations on male British doctors
37. Smoking and death: The past 40 years and the next 40
38. Screening for lung cancer
39. Early Lung Cancer Action Project: Overall design and findings from baseline screening
40. Cancer mortality among Polish migrants to Australia
41. Migration patterns and breast cancer risk in Asian-American women
42. Social class as a prognostic factor in breast cancer survival
43. Deprivation, stage at diagnosis and cancer survival
44. Explaining the relation between education and postmenopausal breast cancer
45. Breast cancer and oral contraceptives - The evidence so far
46. Estrogen replacement therapy and breast cancer risk
47. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
48. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices
49. Dietary fats and cancer
50. Dietary fat and cancer: Consistency of the epidemiologic data, and disease prevention that may follow from a practical reduction in fat consumption
51. Cohort studies of fat intake and the risk of breast cancer - A pooled analysis
52. Overweight as an avoidable cause of cancer in Europe
53. Body size in different periods of life and breast cancer risk in post-menopausal women
54. Diet during adolescence and risk of breast cancer among young women
55. Alcoholic beverage consumption and breast cancer in a French case-control study
56. Consumption of dairy produce and alcohol in a case-control study of breast cancer
57. Alcoholic calories, red wine consumption and breast cancer among premenopausal women
58. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence
59. Sex steroid hormones and genetic susceptibility to breast and prostate cancer
60. Trends in esophageal cancer mortality among US blacks and whites
61. Time-related factors in cancer epidemiology
62. Breast cancer mortality rates are levelling off or beginning to decline in many western countries: Analysis of time trends, age-cohort and age-period models of breast cancer mortality in 20 countries
63. Implications of birth cohort patterns in interpreting trends in breast cancer rates
64. Recent trends in U.S. breast cancer incidence, survival, and mortality rates
65. Birth cohort and calendar period trends in breast cancer mortality in the United States and Canada
66. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening
67. Recent trends in incidence and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use
68. Survival of women with breast cancer in Europe: Variation with age, year of diagnosis and country
69. Recent trends in breast cancer incidence in Sweden
70. Trends in breast cancer mortality among Swedish women 1953-92: Analyses by age, period and birth cohort
71. Evaluation of the effect on breast cancer mortality of population based mammography screening programmes
72. Epidemiology of breast cancer in Japan
73. Cancer in developing countries
74. Trends in breast cancer incidence in greater Bombay: An epidemiological assessment
75. Cancer incidence trends in urban Shanghai, 1972-1994: An update
76. Breast cancer in Singapore: Trends in incidence 1968-1992
77. A case control study on the effectiveness of breast cancer screening by clinical breast examination in Japan
78. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma
79. Histologic types of gastric carcinoma in high- and low-risk areas
80. Association of diet and place of birth with stomach cancer incidence in Hawaii Japanese and Caucasians
81. Stomach cancer and migration within England and Wales
82. Allium vegetables and reduced risk of stomach cancer
83. A case-control study of gastric cancer and diet in Italy
84. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin
85. Intrastrain differences in Helicobacter pylori: A key question in mucosal damage?
86. Epidemiology of gastric cancer and perspectives for prevention
87. The global health burden of infection associated cancers
88. Seroepidemiology of Campylobacter pylori infection in various populations
89. An international association between Helicobacter pylori infection and gastric cancer
90. The etiology of gastric cancer
91. Heterogeneity of Helicobacter pylori
92. Interleukin-1 polymorphisms associated with increased risk of gastric cancer
93. Gastric cancer
94. Gastric cancer in the European Union (1968-1992): Mortality trends and cohort effect
95. Time trends of intestinal and diffuse types of gastric cancer in Norway
96. Time trends in gastric carcinoma: Changing patterns of type and location
97. Unchanged survival of gastric cancer in the southeastern Netherlands since 1982: Result of differential trends in incidence according to Lauren type and subsite
98. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
99. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites
100. Mortality trend from cancer of the gastric cardia in The Netherlands, 1969-1994
101. The cohort effect and Helicobacter pylori
102. Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland
103. Helicobacter pylori and the birth cohort effect: Evidence of a continuous decrease of infection rates in childhood
104. Does daily intake of green-yellow vegetables reduce the risk of cancer in man? An example of the application of epidemiological methods to the identification of individuals at low risk
105. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: A mandate for clinical trials
106. Gastric cancer
107. Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: Design issues and initial data
108. Cancer of the gastro-intestinal tract among Japanese and white immigrants in Los Angeles County
109. Diabetes mellitus and risk of large bowel cancer
110. Postmenopausal hormone use and risk of large-bowel cancer
111. Colorectal cancer
112. Age-period-cohort modeling of colorectal cancer incidence and mortality in Spain
113. Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990
114. Incidence of colorectal carcinoma in the U.S.: An update of trends by gender, race, age, subsite, and stage, 1975-1994
115. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer
116. Variation in colorectal cancer incidence in the United States by subsite of origin
117. Age-period-cohort modelling of large-bowel-cancer incidence by anatomic sub-site and sex in Connecticut
118. Age-period-cohort modelling of large-bowel-cancer incidence by anatomic sub-site and sex in Denmark
119. Trends in colorectal cancer incidence in Sweden 1959-93 by gender, localization, time, period, and birth cohort
120. Colorectal carcinoma among ethnic Chinese in Singapore: Trends in incidence rate by anatomic subsite from 1968 to 1992
121. Colorectal cancer incidence trends by subsite in urban Shanghai, 1972-1994
122. An ecological study of trends in cancer incidence and dietetary changes in Hong Kong
123. Colon cancer incidence: Recent trends in the United States
124. Cancer incidence and mortality trends among whites in the United States, 1947-1984
125. Combined influence of genetic and dietary factors on colorectal cancer incidence in Japanese Americans
126. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas
127. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas
128. Cholangiocarcinoma: Epidemiology, mechanisms of carcinogenesis and prevention
129. Estimates of worldwide incidence of eighteen major cancers in 1985
130. Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis
131. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma
132. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan
133. Nonassociation of aflatoxin with primary liver cancer in a cross-sectional ecological survey in the People's Republic of China
134. Aflatoxin biomarkers
135. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China
136. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma
137. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1
138. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
139. Hepatocellular carcinoma: From gene to public health
140. Aflatoxin B1 induces the transversion of G→T in codon 249 of the p53 tumor suppressor gene in human hepatocytes
141. Geographic variation of p53 mutational profile in nonmalignant human liver
142. Prospective cohort study of risk factors for primary liver cancer in Hiroshima and Nagasaki, Japan
143. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan
144. Cancers weakly related to smoking
145. Net effect of oral contraceptive use on the risk of cancer in women in the United States
146. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis
147. Hepatocellular carcinoma and African iron overload
148. Dietary iron overload as a risk factor for hepatocellular carcinoma in Black Africans
149. Increased risk of death in thorotrast-exposed patients during the late follow-up period
150. Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis
151. Liver cancer
152. Trends in mortality from primary liver cancer in Europe
153. Trends in primary liver cancer
154. Alcohol consumption as a major risk factor for the rise in liver cancer mortality rates in Japanese men
155. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population
156. Cancer incidence and survival in Osaka
157. Worldwide patterns and trends in mortality from liver cirrhosis, 1955 to 1990
158. Trends in primary liver cancer
159. Rising incidence of hepatocellular carcinoma in the United States
160. Viral hepatitis. New light on an old disease
161. Viral hepatitis, type B (MS-2 strain) prevention with specific hepatitis B immune serum globulin
162. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine
163. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study
164. Design and compliance of HBV vaccination trial on newborns to prevent hepatocellular carcinoma and 5-year results of its pilot study
165. The Gambia Hepatitis Intervention Study
166. Hepatitis B vaccination in infancy in The Gambia: Protection against carriage at 9 years of age
167. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children
168. Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China
169. Studies on the chemotherapy of human opisthorchiasis in Thailand: I. Clinical trial of praziquantel
170. Rate of re-infection by Opisthorchis viverrini in an endemic northeast Thai community after chemotherapy
171. Screening for hepatocellular carcinoma
172. Prospective study of early detection for primary liver cancer
173. Prostate carcinoma incidence and patient mortality: The effects of screening and early detection
174. Geographic pathology of latent prostatic carcinoma
175. Possible underestimation of the incidence rate of prostate cancer in Japan
176. Genetic predisposition to prostate cancer: Possible explanations for ethnic differences in risk
177. Rise in prostatic cancer incidence associated with increased use of transurethral resection
178. The role of increasing detection in the rising incidence of prostate cancer
179. Cancer surveillance series: Interpreting trends in prostate cancer - Part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates
180. Cancer surveillance series: Interpreting trends in prostate cancer - Part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality
181. Cancer surveillance series: Interpreting trends in prostate cancer - Part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality
182. Prostate cancer screening in the midst of controversy: Canadian men's knowledge, beliefs, utilization, and future intentions
183. The diagnosis, management, treatment and costs of prostate cancer in England and Wales
184. Prostate cancer screening (II): Is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990
185. Prostate cancer in Western Australia: Trends in incidence and mortality from 1985 to 1996
186. Trends in incidence and mortality rates for prostate cancer before and after prostate-specific antigen introduction. A registry-based study in southeastern Netherlands 1971-1995
187. International trends and patterns of prostate cancer incidence and mortality
188. Cancer of the prostate: A nutritional disease?
189. Prostate Cancer Prevention Trial (PCPT) update
190. Prostate Cancer
191. Prospective evaluation plan for randomised trials of prostate cancer screening
192. Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam)
193. International incidence rates of invasive cervical cancer after introduction of cytological screening
194. Is HIV infection a cofactor for cervical squamous cell neoplasia?
195. Strategies for global control of cervical cancer
196. Improved control of invasive cervical cancer in Sweden over six decades by earlier clinical detection and better treatment
197. Risk indicators of breast and cervical cancer on ecologic and individual levels
198. The Icelandic and Nordic cervical screening programs: Trends in incidence and mortality rates through 1995
199. Cohort mortality from carcinoma of the cervix
200. Trends in cervical cancer and carcinoma in situ in Great Britain
201. The impact of screening on the incidence of cervical cancer in England and Wales
202. Increasing mortality from cancer of the cervix in young Australian women
203. Trends in cervical cancer in New Zealand
204. Cervical cancer mortality in Belgium, 1955-1989. A descriptive study
205. Epidemiological evaluation of cervical cancer screening in Slovenia up to 1986
206. Recent trends in uterine cervix cancer in Slovakia, 1968-1987
207. Increase in cervical cancer mortality in Spain, 1951-1991
208. Cervical cancer
209. Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: Recent increase in cervical cancer incidence
210. Trends in cancer of the cervix uteri in Sweden following cytological screening
211. Effect of screening on incidence of and mortality from cancer of cervix in England: Evaluation based on routinely collected statistics
212. International trends in incidence of cervical cancer: II. Squamous-cell carcinoma
213. Adenocarcinomas of the uterine cervix: The epidemiology of an increasing problem
214. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas
215. Diagnostic problems of in situ and invasive adenocarcinomas of the uterine cervix
216. Quality assurance in cervical cancer screening: The Icelandic experience 1964-1993
217. Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: No strong evidence of benefit
218. Oral contraceptive use and adenocarcinoma of cervix
219. Evaluation model of the Mexican national program for early cervical cancer detection and proposals for a new approach
220. Evaluation of the cervical cancer control program in Cuba
221. Screening for cervical cancer in Latin America: A case-control study
222. Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997
223. Trends in morbidity and mortality for oesophageal cancer in Linxian County, 1959-1983
224. Esophageal cancer
225. The spatial distribution of oesophageal carcinoma in the Transkei, South Africa
226. Mortality from cancer of the oesophagus in Brittany
227. Cancer of the oesophagus in Brittany: An incidence study in Ille-et-Vilaine
228. Cancer in Jewish migrants to Israel
229. Esophageal cancer and aldehyde dehydrogenase-2 genotypes in Japanese males
230. Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics
231. Oesophageal cancer
232. Oesophageal cancer mortality in Europe: Paradoxical time trend in relation to smoking and drinking
233. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia
234. Adenocarcinomas of the esophagus and gastric cardia: Medical conditions, tobacco, alcohol, and socioeconomic factors
235. Obesity, alcohol and tobacco as risk factors for cancer of the esophagus and gastric cardia: Adenocarcinoma vs squamous cell cancer
236. Importance of anatomical subsite in correlating risk factors in cancer of the oesophagus - Report of a case-control study
237. Vegetables, fruit and cancer: I. Epidemiology
238. Adenocarcinoma of the esophagus: Role of obesity and diet
239. Oesophageal cancer in never-smokers and never-drinkers
240. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia
241. Adenocarcinoma of the esophagus and esophageal junction in white men: Alcohol, tobacco, and socio-economic factors
242. Risk factors for oesophageal cancer in Northeast China
243. Tea and cancer
244. Reduced risk of esophageal cancer associated with green tea consumption
245. Diet and squamous-cell cancer of the oesophagus: A French multicentre case-control study
246. Hot beverages and oesophageal cancer in southern Brazil: A case-control study
247. Ingested mutagens from opium and tobacco pyrolysis products and cancer of the oesophagus
248. Mutagens produced by the pyrolysis of opium and its alkaloids as possible risk factors in cancer of the bladder and oesophagus
249. Aetiology of oesophageal cancer: Some operative factors
250. No effect of riboflavine, retinol, and zinc on prevalence of precancerous lesions of oesophagus. Randomised double-blind intervention study in high-risk population of China
251. Continuing climb in rates of oesophageal adenocarcinoma of the esophageal adenocarcinoma: An update
252. Linxian nutrition intervention trials. Design, methods, participant characteristics, and compliance
253. Incidence of cancer of the oesophagus, cardia and stomach in Denmark
254. The rising trend in oesophageal adenocarcinoma and gastric cardia
255. Time trends in oesophageal cancer incidence in Côte D'Or (France) 1976-93
256. Recent time trends in cancer of the oesophagus and gastric cardia in the region of Calvados in France, 1978-1995: A population based study
257. Esophageal and gastric carcinoma in Norway 1958-1992: Incidence time trend variability according to morphological subtypes and organ subsites
258. Oesophageal and gastric cancer in Scotland 1960-90
259. Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden
260. Rising incidence of adenocarcinoma of the esophagus and gastric cardia
261. Time trend and age-period-cohort effects of incidence of oesophageal cancer in Connecticut 1935-89
262. Incidence trends in oesophageal and proximal gastric carcinoma in Victoria
263. Trends in incidence rates of adenocarcinoma of the oesophagus and gastric cardia in New Zealand, 1978-1992
264. Declining incidence is greater for oesophageal then gastric cancer in Shanghai, People's Republic of China
265. Increased alcohol-related oesophageal cancer mortality rates in Japanese men
266. Bayesian analysis of survival on multiple time scales
267. Precision of incidence predictions based on Poisson distributed observations
268. A simple non-linear model in incidence prediction
269. The role of the elderly and their support within changing family structures in developing countries
270. The urban environment, poverty and health in developing countries
271. Demographic and epidemiologic trends affecting health policy in developing countries
272. Urbanization and health in developing countries
273. Urban nutrition in developing countries
274. Social differences in sexual behaviour and cervical cancer
275. Reproductive factors and breast cancer
276. Urban and rural factors in the aetiology of cancer
277. The age distribution of cancer and a multi-stage theory of carcinogenesis
278. Population aging and health
279. Health care economics of cancer in the elderly
280. Declining lung cancer rates among young men and women in the United States: A cohort analysis
281. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths
282. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population
283. Combined oral contraceptives and liver cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives
284. Environmental carcinogenesis: Misconceptions and limitations to cancer control